We report on two cases of prenatal diagnosis of myotonic dystrophy (DM), using flanking markers APOC2 or CKMM on the proximal side and D19S51 on the distal side. By double digestion (TaqI and NcoI) of PCR amplified CKMM, the informativeness was increased from a PIC value of 0*57 to 0-69. Altogether, with a PIC value of 0-64 for APOC2, 0.69 for CKMM, and 0-27 for D19S51 (BglI), presymptomatic and prenatal diagnosis can thus be offered to approximately 24% of persons with a risk between 0-0004 and 00008 using these flanking markers.
Myotonic dystrophy (DM), the most common form of adult muscular dystrophy, is an autosomal dominant disorder characterised by a marked variability in both age at onset and clinical severity.' DM ranges in expression from a congenital form that is frequently fatal in the newborn period to an asymptomatic condition associated with normal longevity. The major clinical features include myotonia, muscle weakness, lens opacities, and intellectual impairment.' Congenital DM is characterised by neonatal hypotonia and respiratory difficulties with mental retardation. Carrier mothers, whether affected or not, have a high risk of giving birth to congenitally affected infants. Determination of the carrier status for asymptomatic subjects and prenatal diagnosis for fetuses at risk is therefore requested by an increasing number of families.
Family studies have shown that the locus for DM fig 1, the fetus in family 1 (III.2) displayed the CKMM haplotype 3 and the DJ9S51 allele 1. The mother elected to terminate the pregnancy since the fetus had the haplotype associated with DM with a high risk of being affected. In family 2 (fig 2) the mother (II.7) did not transmit the alleles associated with DM to her fetus (III.1), 2 for APOC2 and 1 for D19S51 (Southern blots not shown).
Discussion
In family 1, the risk of the fetus being affected was estimated at 0-980 with CKMM as the only marker, using the LINKAGE program.10 The risk was significantly increased to 09996, using both CKMM and D19S51 for the calculation. In family 2, the risk was estimated at 010008. Altogether, with a PIC value of 0-64 for APOC2, 0-69 for CKMM, and 0-27 for DJ9S51 (BglI), presymptomatic and prenatal diagnosis can be offered to approximately 24% of persons with a risk between 010004 and 0-0008, which is now quite acceptable, using these flanking markers. However, the assignment of D19S51 distal to the DM locus is based on only one informative crossover event5 and should therefore be regarded as provisional until confirmed by further family studies. 
